Given the relevance of Cx30, Cx36, and Cx43 in the CNS, we provide an overview of the regulatory mechanisms involved in the expression of these Cxs and their role in brain cancer, CNS disorders, and neuroprotection. This evidence concerns the gene GJD2 and central nervous system disorder.